19 May 2013
Keywords: integrated, biopharma, anthrax, vaccine, deal, navy, nucycle
Article | 27 September 2004
NuCycle Therapy, a wholly-owned subsidiary of Integrated BioPharma, has entered into an R&D agreement with the US Navy to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
27 September 2004
17 May 2013
© 2013 thepharmaletter.com